New Study on Ivermectin ‘Should Convince Any Naysayer’: Dr. Pierre Kory

Zachary Stieber
Zachary Stieber
Senior Reporter
&
Jan Jekielek
Jan Jekielek
Senior Editor
|Updated:

A recently published study indicating the anti-parasitic ivermectin worked well as a prophylactic against the virus that causes COVID-19 should help sway critics of the drug, according to Dr. Pierre Kory, president of the Front Line COVID-19 Critical Care Alliance (FLCCC).

“That should convince any naysayer,” Kory told The Epoch Times’ “American Thought Leaders.“ ”What they found was astounding.”
Related Topics